SAB Biotherapeutics, Inc. SABSW
Set alert
0.00 USD 0.00 -74.42%
As of Oct 22, 3:59 PM ET
0.0001 Day range 0.0126
0.0001 52-week range 0.0126
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0477
- Prev close
- 0.0043
- Mkt cap
- 10.51K
- Vol
- 581.55K
- Avg vol
- 0
- EPS
- 0.292
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0126
- Forward P/E
- 0.00
- Beta
- 0.64
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-0.34 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 17.0×
FY 2019 5y median -1.0× FY 2025
P/S 0.0×
FY 2019 5y median 3.5× FY 2025
P/B 0.5×
FY 2019 5y median 0.8× FY 2025
P/FCF -1.6×
FY 2019 5y median -1.5× FY 2025
EV/EBITDA 4.1×
FY 2019 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.7× FY 2025
FCF Yield -63.3%
FY 2019 5y median -66.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median -121.0% FY 2025
Net Margin 0.0%
FY 2019 5y median -78.4% FY 2025
ROE 8.8%
FY 2019 5y median -60.3% FY 2025
ROIC -30.0%
FY 2019 5y median -50.8% FY 2025
ROA 7.7%
FY 2019 5y median -36.8% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2019 FY 2025
Operating Income -14.1%
FY 2019 FY 2025
EPS (diluted) 78.5%
FY 2019 FY 2025
Free Cash Flow -32.0%
FY 2019 FY 2025
Financial Health
Current Ratio 9.5×
FY 2019 5y median 3.0× FY 2025
Quick Ratio 9.5×
FY 2019 5y median 3.0× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA -0.3×
FY 2019 5y median 0.6× FY 2025
Interest Coverage -203×
FY 2019 5y median -121× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31